Clomicalm Patent Expiration

Clomicalm Petitions

Details of Clomicalm's suitability petitions are listed below.

Petitioner Action Date of Action Description
Petitions Data
PetMedicus Laboratories Ltd. Approved 19 Jun, 2009 The generic product will differ in dosage form and tablet strength. The pioneer product is an unscored tablet available in 5 mg, 20 mg, 40 mg, and 80 mg strengths. The proposed generic product is a unique, bi-layered, quadrisected tablet that will be available in 10 mg and 80 mg strengths.

About Clomicalm

Clomicalm is a drug owned by VIRBAC AH, INC. Clomicalm uses Clomipramine Hydrochloride as the active ingredient.

Active Ingredient:

Clomicalm uses Clomipramine Hydrochloride as the active ingredient. Check out other Drugs and Companies using Clomipramine Hydrochloride ingredient.